Iron metabolism impairment has been viewed as a major feature of CKD-associated anemia and hepcidin (de)regulation is one of the key pieces for resistance to rHuEPO therapy [29,30,58,59,60]. This evidence concerns the gene HAMP and chronic kidney disease.